These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

696 related items for PubMed ID: 22356587

  • 1. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
    Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, Sokol H, Coffin B, Sabaté JM.
    Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
    [Abstract] [Full Text] [Related]

  • 2. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
    Dior M, Delagrèverie H, Duboc H, Jouet P, Coffin B, Brot L, Humbert L, Trugnan G, Seksik P, Sokol H, Rainteau D, Sabate JM.
    Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
    [Abstract] [Full Text] [Related]

  • 3. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.
    Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A.
    Am J Gastroenterol; 2005 Feb; 100(2):373-82. PubMed ID: 15667495
    [Abstract] [Full Text] [Related]

  • 5. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.
    Rajilić-Stojanović M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM.
    Gastroenterology; 2011 Nov; 141(5):1792-801. PubMed ID: 21820992
    [Abstract] [Full Text] [Related]

  • 6. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y.
    Neurogastroenterol Motil; 2012 Jun; 24(6):521-30, e248. PubMed ID: 22339879
    [Abstract] [Full Text] [Related]

  • 7. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota.
    Crouzet L, Gaultier E, Del'Homme C, Cartier C, Delmas E, Dapoigny M, Fioramonti J, Bernalier-Donadille A.
    Neurogastroenterol Motil; 2013 Apr; 25(4):e272-82. PubMed ID: 23433203
    [Abstract] [Full Text] [Related]

  • 8. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
    Chassard C, Dapoigny M, Scott KP, Crouzet L, Del'homme C, Marquet P, Martin JC, Pickering G, Ardid D, Eschalier A, Dubray C, Flint HJ, Bernalier-Donadille A.
    Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951
    [Abstract] [Full Text] [Related]

  • 9. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
    Peleman C, Camilleri M, Busciglio I, Burton D, Donato L, Zinsmeister AR.
    Clin Gastroenterol Hepatol; 2017 May; 15(5):720-727.e1. PubMed ID: 27856362
    [Abstract] [Full Text] [Related]

  • 10. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.
    Parkes GC, Rayment NB, Hudspith BN, Petrovska L, Lomer MC, Brostoff J, Whelan K, Sanderson JD.
    Neurogastroenterol Motil; 2012 Jan; 24(1):31-9. PubMed ID: 22070725
    [Abstract] [Full Text] [Related]

  • 11. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R, Ghoshal U, Dhole TN, Ghoshal UC.
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [Abstract] [Full Text] [Related]

  • 12. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
    Zhan K, Wu H, Xu Y, Rao K, Zheng H, Qin S, Yang Y, Jia R, Chen W, Huang S.
    mSystems; 2024 Mar 19; 9(3):e0129923. PubMed ID: 38329942
    [Abstract] [Full Text] [Related]

  • 13. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome.
    Carroll IM, Ringel-Kulka T, Keku TO, Chang YH, Packey CD, Sartor RB, Ringel Y.
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov 19; 301(5):G799-807. PubMed ID: 21737778
    [Abstract] [Full Text] [Related]

  • 14. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
    Duboc H, Rajca S, Rainteau D, Benarous D, Maubert MA, Quervain E, Thomas G, Barbu V, Humbert L, Despras G, Bridonneau C, Dumetz F, Grill JP, Masliah J, Beaugerie L, Cosnes J, Chazouillères O, Poupon R, Wolf C, Mallet JM, Langella P, Trugnan G, Sokol H, Seksik P.
    Gut; 2013 Apr 19; 62(4):531-9. PubMed ID: 22993202
    [Abstract] [Full Text] [Related]

  • 15. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W, Wang HF, Zhang Y, Zhang YL, Niu BY, Yao SK.
    World J Gastroenterol; 2020 Dec 07; 26(45):7153-7172. PubMed ID: 33362374
    [Abstract] [Full Text] [Related]

  • 16. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
    Li G, Yang M, Jin Y, Li Y, Qian W, Xiong H, Song J, Hou X.
    J Gastroenterol Hepatol; 2018 Jun 07; 33(6):1220-1226. PubMed ID: 29194775
    [Abstract] [Full Text] [Related]

  • 17. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N, Ringel Y, Katibian D, Lundqvist A, Sartor RB, Carroll IM, Ringel-Kulka T.
    Dig Dis Sci; 2018 Jul 07; 63(7):1890-1899. PubMed ID: 29777439
    [Abstract] [Full Text] [Related]

  • 18. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, Molnár T, Lonovics J, Garcia-Villar R, Fioramonti J, Wittmann T, Bueno L.
    Clin Gastroenterol Hepatol; 2007 May 07; 5(5):550-5. PubMed ID: 17336590
    [Abstract] [Full Text] [Related]

  • 19. Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.
    Andrews CN, Griffiths TA, Kaufman J, Vergnolle N, Surette MG, Rioux KP.
    Aliment Pharmacol Ther; 2011 Aug 07; 34(3):374-83. PubMed ID: 21671966
    [Abstract] [Full Text] [Related]

  • 20. [The composition of the gastrointestinal mucosa-associated microbiota in irritable bowel syndrome patients].
    Loranskaia ID, Boldyreva MN, Lavrent'eva OA.
    Eksp Klin Gastroenterol; 2013 Aug 07; (3):15-22. PubMed ID: 24294767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.